The inside story from Aspen on Covid-19 Dexamethasone: MUST LISTEN

Loading player...
This week, the world woke up to the exciting news that Dexamethasone, a cheap drug in the Aspen stable, dramatically improves the chances of survival for people seriously ill in hospitals with Covid-19. The Aspen share price has jumped up in value on the Johannesburg stock exchange as investors anticipate high demand for Dexamethasone. In this interview with BizNews founder Alec Hogg, Aspen group senior executive Stavros Nicolaou shares the details of what is known about Dexamethasone and how it will be made available. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Jun 2020 2PM English South Africa Investing · Business News

Other recent episodes

Golden handshakes, protection of allies, targeting of whistleblowers… - Grant Abbott

In his latest interview with Chris Steyn, Grant Abbott the General Secretary of the National Tertiary Education Union (NTEU) shares evidence collected over years for the criminal complaint lodged against Vice-Chancellor Professor Sakhela Buhlungu who was recently placed on precautionary suspension by the Council and now faces charges of gross…
15 Jun 5AM 19 min